Suchergebnisse - "Curtin, Nicola"

PubPharm (127)

81

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

enthalten in: Breast cancer research | 2013

von Eccles, S. | Aboagye, E. | Ali, S. | +84

82

Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies

enthalten in: Haematologica | 2013

von Gaymes, T. | Mohamedali, A. | Patterson, M. | +8

83

1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity

enthalten in: Journal of medicinal chemistry | 2013

von Cano, C. | Saravanan, K. | Bailey, C. | +14

84

Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer

enthalten in: Molecular cancer therapeutics | 2013

von Batey, M. | Zhao, Y. | Kyle, S. | +6

85

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

enthalten in: Cancer chemotherapy and pharmacology | 2013

von Plummer, R. | Lorigan, P. | Steven, N. | +10

86

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

enthalten in: Cancer chemotherapy and pharmacology | 2013

von Plummer, R. | Lorigan, P. | Steven, N. | +10

87

A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation

enthalten in: Cancer chemotherapy and pharmacology | 2013

von Plummer, R. | Lorigan, P. | Steven, N. | +10

88

DNA repair dysregulation from cancer driver to therapeutic target

enthalten in: Nature reviews. Cancer | 2012

von Curtin, N.

89

Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers : sensitivity to PARP inhibitors, platinum, and survival

enthalten in: Cancer research | 2012

von Mukhopadhyay, A. | Plummer, E. | Elattar, A. | +8

90

Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K

enthalten in: Molecular cancer therapeutics | 2012

von Munck, J. | Batey, M. | Zhao, Y. | +15